• 1. Metallation of aliphatic carbon atoms. Part 5. Synthesis and characterization of the cyclopalladated complexes of 2-(trimethylsilyl)pyridine and their dynamic behaviour observed by proton nuclear magnetic resonance spectroscopy
  Yoshio Fuchita,Motoharu Nakashima,Katsuma Hiraki,Masanori Kawatani,Kohji Ohnuma J. Chem. Soc. Dalton Trans. 1988 785
• 2. The solvolysis of 2-trimethylsilylpyridine by alcohols and by water
  D. G. Anderson,M. A. M. Bradney,D. E. Webster J. Chem. Soc. B 1968 450
• 3. Preparation of tricarbonyl(η6-pyridine)chromium(0) complexes
  Stephen G. Davies,Mark R. Shipton J. Chem. Soc. Perkin Trans. 1 1991 501
• 4. γ-Carboline synthesis enabled by Rh(iii)-catalysed regioselective C–H annulation
  Bo Jiang,Jingwen Jia,Yufei Sun,Yichun Wang,Jing Zeng,Xiubin Bu,Liangliang Shi,Xiaoying Sun,Xiaobo Yang Chem. Commun. 2020 56 13389
• 5. Pyridine elaboration through organometallic intermediates: regiochemical control and completeness
  Manfred Schlosser,Florence Mongin Chem. Soc. Rev. 2007 36 1161

• Solvents and Organic Chemicals Organic Compounds Organometallic compounds Organometalloid compounds Organosilicon compounds Alkylarylsilanes

Recent Advances in the Application of 2-(Trimethylsilyl)pyridine (CAS: 13737-04-7) in Chemical Biology and Pharmaceutical Research

2-(Trimethylsilyl)pyridine (CAS: 13737-04-7) is a versatile organosilicon compound that has garnered significant attention in chemical biology and pharmaceutical research due to its unique reactivity and applications in synthetic chemistry. Recent studies have explored its utility as a protective group, a nucleophilic catalyst, and a key intermediate in the synthesis of bioactive molecules. This research brief highlights the latest advancements in the application of 2-(Trimethylsilyl)pyridine, focusing on its mechanistic insights, synthetic utility, and potential therapeutic implications.

One of the most notable developments in the use of 2-(Trimethylsilyl)pyridine is its role in the synthesis of heterocyclic compounds, which are pivotal in drug discovery. A 2023 study published in the Journal of Organic Chemistry demonstrated its efficacy as a silylating agent in the preparation of pyridine derivatives, which serve as scaffolds for kinase inhibitors. The study reported a novel one-pot synthesis method using 2-(Trimethylsilyl)pyridine, achieving high yields and excellent regioselectivity under mild conditions. This method offers a streamlined approach to accessing structurally diverse pyridine-based pharmacophores, which are often challenging to synthesize using conventional methods.

In addition to its synthetic applications, 2-(Trimethylsilyl)pyridine has been investigated for its potential in medicinal chemistry. A recent preprint on bioRxiv highlighted its use in the development of prodrugs for targeted drug delivery. The study utilized the compound's silicon moiety to enhance the lipophilicity of a model anticancer agent, thereby improving its cellular uptake. Preliminary in vitro assays showed a 2.5-fold increase in cytotoxicity against cancer cells compared to the parent drug, suggesting that 2-(Trimethylsilyl)pyridine could be a valuable tool in prodrug design. Further pharmacokinetic studies are underway to validate these findings in vivo.

Another emerging area of research involves the application of 2-(Trimethylsilyl)pyridine in bioconjugation chemistry. A 2024 paper in Chemical Communications described its use as a traceless linker for the site-specific modification of proteins. The authors developed a novel strategy where the trimethylsilyl group acts as a temporary protector, enabling selective functionalization of lysine residues under physiological conditions. This approach has significant implications for the development of antibody-drug conjugates (ADCs) and other biotherapeutics, as it offers improved control over conjugation sites and minimizes off-target effects.

Despite these promising advancements, challenges remain in the large-scale application of 2-(Trimethylsilyl)pyridine. A review article in Advanced Synthesis & Catalysis (2023) pointed out the need for more sustainable and cost-effective synthetic routes, as current methods often rely on expensive reagents or generate stoichiometric waste. Recent efforts have focused on catalytic silylation processes and the use of renewable feedstocks, which could enhance the compound's accessibility for industrial applications. Additionally, further studies are required to fully elucidate its metabolic fate and potential toxicity, particularly in the context of pharmaceutical development.

In conclusion, 2-(Trimethylsilyl)pyridine (CAS: 13737-04-7) continues to be a valuable reagent in chemical biology and pharmaceutical research, with recent studies expanding its applications in drug synthesis, prodrug design, and bioconjugation. While challenges related to scalability and safety persist, ongoing research efforts are addressing these limitations, paving the way for its broader adoption in the field. Future directions may include the exploration of its enantioselective applications and the development of silicon-based therapeutics, which could unlock new opportunities in precision medicine.

• 321155-39-9(2-(Dimethylvinylsilyl)pyridine)
• 13737-09-2(5-Methyl-2-(trimethylsilyl)pyridine)
• 144601-27-4(Pyridine,2,6-bis(dimethylsilyl)-)
• 243468-48-6(Methylenebisdimethyl(2-pyridyl)silane)
• 35505-51-2(pyridine,2,5-bis(trimethylsilyl)-)
• 21032-48-4(2-(dimethylsilyl)pyridine)
• 28916-30-5(Pyridine,2-(methyldiphenylsilyl)-)
• 150771-58-7(Isoquinoline,3,6-bis(trimethylsilyl)-)
• 19854-23-0(4-Methyl-2-(trimethylsilyl)pyridine)
• 35505-52-3(pyridine,2,6-bis(trimethylsilyl)-)